Abstract:OBJECTIVE:To investigate the effects of the carboxyl end of osteogenic growth peptide (OGP)-OGP((10-14)) and its derivative G38I on the proliferation and differentiation of osteoblasts (OBs).METHODS:Osteoblasts were isolated from the calvariae of newborn SD rats and cultured to G3. OGP((10-14)) or G38I of the concentrations of 10(-15) to 10(-7) mol/L were added to culture medium for 48 hours respectively. The number of cells was counted and MTT analysis was used to examine the proliferation of the cells. The ultrastructure of cells was investigated by electron microscopy. The osteoblasts of G3 were divided into experimental groups, treated with OGP((10-14)) or G38I of the concentration of 10(-11) mol/L for 48 hours, and control group. The alkaline phosphatase activity in the culture medium was measured. The protein expression level of type-I collagen was evaluated by immunohistochemistry. The core binding factor 1 (Cbfa1) and type-I collagen mRNA level of osteoblasts were determined by RT-PCR.RESULTS:With a biphasic effect on, OGP((10-14)) and G38I stimulated the number enhancement of OBs dose-dependently at low concentration and inhibited it at high concentration. The numbers of OB were the highest (37 x 10(4)/ml +/- 7 x 10(4)/ml and 30 x 10(4)/ml +/- 5 x 10(4)/ml respectively) when treated by OGP((10-14)) or G38I of the concentration of 10(-11)mol/L. The rough endoplasm net was flourishing and the secreting vesicle was abounding in the experimental cells. There was calcium crystal in the control cells. The activity of alkaline phosphatase in the culture medium of the OGP (10(-14)) and G38I groups were higher than that in the control group (4.47 U/g and 3.82 U/g vs 2.21 U/g). The protein expression level of type-I collagen was higher and the mRNA levels of Cbfa1 and type-I collagen were higher in the OGP((10-14)) and G38I groups were increased in the experimental groups in comparison with the control group (P < 0.05, P < 0.01, and P < 0.05).CONCLUSION:They stimulated cell number enhancement dose dependently at low concentration and followed by inhibition at high concentration. Just as the native OGP, OGP((10-14)) and its derivative G38I stimulate the proliferation of osteoblasts, and improve their activity, up-regulate the Cbfa1 and type-I collagen mRNA expression levels and increase the collagen synthesis, thus promoting the differentiation and osteogenic effect of osteoblasts.

Effect of Rhigf-1 on the Proliferation and Differentiation and OPG,RANKL Gene Expression in Rat Osteoblast

Effect of Recombinant Human Insulin-Like Growth Factor (Rhigf-ⅰ) on the Proliferation, Apoptosis and Type Ⅰ Collagen Synthesis of Cultured Rat Osteoblasts

Role of OPG/RANKL/RANK system during alveolar bone resorption and remodeling

Effects of recombinant human insulin-like growth factor on rat osteoblasts

Effects of IGF-Ⅱon MC3T3-E1 Cells Proliferation and Nitric Oxide Production

The effects of OGP(10-14) and its derivatives on osteoblasts in vitro

[Effect of Herba Epimedii Flavone on Expression of OPG and RANKL in Rat Osteoblasts].

Molecular Mechanisms of Rhpth(1-34) Influence on Osteoporosis in Ovariectomized Rats

Effects of OGP_(10-14) and its analogue G48A on expression of Cbfα1 and IGF-1 mRNA in osteoblasts

Effect of recombinant human osteoprotegerin on rabbit osteoclasts in vitro

[Effects of OGP(10-14) and Its Derivative G38I on Proliferation and Differentiation of Rat Osteoblasts in Vitro].

Effects of Bone Formation on Culture Osteoblasts with Rhpth(1-34) in Vitro

Effect of zoledronic acid on osteoprotegerin and tumor necrosis factor alpha mRNA expression in rats

Influcnce of Raloxifene on Proliferation, Differentiation and Mineralization of Osteoblasts in Rats

Effects of IGF-II on promoting proliferation and regulating nitric oxide synthase gene expression in mouse osteoblast-like cell

Effect of Bone Peptide on Functions of Bone Formation and Bone Resorption in Osteoporotic Model Rats

Gene expression profiles and bioinformatics analysis of insulin‐like growth factor‐1 promotion of osteogenic differentiation

Effect of P38mapk Inhibition on Receptor Activator of Nuclear Factor-Κb Ligand and Osteoprotegerin Expressions in Osteoblasts

Feasibility of recombinant plasmid pEGFP-N1-IGF-1 transfection in an osteoporosis rat

Effects of IL-1β on OPG and RANKL mRNA expression in human periodontal ligament fibroblasts

Differentiation and osteoprotegerin secretion of human osteoblasts:R-spondin 1 effect via Wnt/beta-catenin signal pathway